Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Intracoastal Capital, LLC and Aethlon Medical Inc (AEMD)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Mitchell P. Kopin 0 909,090 0 909,090 909,090 5.7%
Daniel B. Asher 0 909,090 0 909,090 909,090 5.7%
Intracoastal Capital 0 909,090 0 909,090 909,090 5.7%

Page 1 of 8 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of
1934

 

(Amendment No. )*

Aethlon Medical, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

00808Y208

(CUSIP Number)

October 2, 2017

(Date of Event Which Requires Filing of
this Statement)

Check the appropriate box to designate
the rule pursuant to which this Schedule is filed:

a. Rule 13d-1(b)
b. Rule 13d-1(c)
c. Rule 13d-1(d)

* The remainder of this cover page
shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior
cover page.

The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).

Page 1 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 2 of 8 – SEC Filing

CUSIP No.          00808Y208

1.

Names of Reporting Persons.

Mitchell P. Kopin

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

3.

SEC Use Only

4.

Citizenship or Place of Organization

United States of America

Number of

Shares

Beneficially

Owned by
Each Reporting

Person With:

5.

Sole Voting Power

0

6.

Shared Voting Power

909,090

7.

Sole Dispositive Power

0

8.

Shared Dispositive Power

909,090

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

909,090 (see Item 4)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)

11.

Percent of Class Represented by Amount in Row (9)

5.7% (see Item 4)

12.

Type of Reporting Person (See Instructions)

IN; HC

Page 2 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 3 of 8 – SEC Filing

CUSIP No.          00808Y208

1.

Names of Reporting Persons.

Daniel B. Asher

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

3.

SEC Use Only

4.

Citizenship or Place of Organization

United States of America

Number of

Shares

Beneficially

Owned by
Each Reporting

Person With:

5.

Sole Voting Power

0

6.

Shared Voting Power

909,090

7.

Sole Dispositive Power

0

8.

Shared Dispositive Power

909,090

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

909,090 (see Item 4)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)

11.

Percent of Class Represented by Amount in Row (9)

5.7% (see Item 4)

12.

Type of Reporting Person (See Instructions)

IN; HC

Page 3 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 4 of 8 – SEC Filing

CUSIP No.          00808Y208

1.

Names of Reporting Persons.

Intracoastal Capital LLC

2.

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)

(b)

3.

SEC Use Only

4.

Citizenship or Place of Organization

United States of America

Number of

Shares

Beneficially

Owned by
Each Reporting

Person With:

5.

Sole Voting Power

0

6.

Shared Voting Power

909,090

7.

Sole Dispositive Power

0

8.

Shared Dispositive Power

909,090

9.

Aggregate Amount Beneficially Owned by Each Reporting Person

909,090 (see Item 4)

10.

Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)

11.

Percent of Class Represented by Amount in Row (9)

5.7% (see Item 4)

12.

Type of Reporting Person (See Instructions)

OO

 

Page 4 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 5 of 8 – SEC Filing

Item 1.

(a) Name of Issuer

Aethlon Medical, Inc. (the
Issuer”)

(b) Address of Issuer’s Principal
Executive Offices

8910 University Center Lane, Suite
660

San Diego, California 92122

Item 2.

(a) Name of Person Filing

(b) Address of Principal Business Office or, if none,
Residence

(c) Citizenship

This Schedule 13G is being filed
on behalf of (i) Mitchell P. Kopin, an individual who is a citizen of the United States of America (“Mr. Kopin”),
(ii) Daniel B. Asher, an individual who is a citizen of the United States of America (“Mr. Asher”) and (iii)
Intracoastal Capital LLC, a Delaware limited liability company (“Intracoastal” and together with Mr. Kopin and
Mr. Asher, collectively the “Reporting Persons”).

The Reporting Persons have entered
into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which the
Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities
Exchange Act of 1934, as amended.

The principal business office
of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483.

The principal business office
of Mr. Asher is 111 W. Jackson Boulevard, Suite 2000, Chicago, Illinois 60604.

(d) Title of Class of Securities

Common stock, $0.001 par value
per share, of the Issuer (the “Common Stock”).

(e) CUSIP Number

00808Y208

 

Item 3. If this statement is filed pursuant
to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

Item
4. Ownership.

(a) and (b):

(i)       Immediately
following the execution of the Securities Purchase Agreement with the Issuer on October 2, 2017 (the “SPA”)
(as disclosed by the Issuer with the Securities and Exchange Commission on October 3, 2017),
each of the Reporting Persons
may be deemed to have beneficial ownership of 993,459 shares of Common Stock, which consisted of
(i)
909,090 shares of Common Stock that was to be issued
to Intracoastal at the closing of the transactions contemplated by the SPA and (ii) 84,369 shares of Common Stock issuable upon
exercise of a warrant that was to be issued to Intracoastal at the closing of the transactions contemplated by the SPA (the “Intracoastal
Warrant
”),
and all such shares of Common Stock in the aggregate represent beneficial ownership of approximately
9.99% of the Common Stock, based on (1) 8,951,081
shares of Common Stock outstanding as of September 7, 2017 as reported by the Issuer, plus (2)
909,090 shares of Common Stock that was to be issued to Intracoastal at the closing of the
transactions contemplated by the SPA and (3) 84,369 shares of Common Stock issuable upon exercise of the Intracoastal Warrant
.
The foregoing excludes 824,721 shares of Common Stock issuable upon exercise of the Intracoastal
Warrant b
ecause the Intracoastal Warrant contains a blocker provision under
which the holder thereof does not have the right to exercise the Intracoastal Warrant to
the extent that such exercise would result in beneficial ownership by the holder thereof, together with the holder’s affiliates
and any other persons acting as a group together with the holder or any of the holder’s affiliates, of more than 9.99% of
the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership
of 1,818,180 shares of Common Stock.

Page 5 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 6 of 8 – SEC Filing

(ii)       As
of close of business on October 11, 2017, each of the Reporting Persons may have been deemed to have beneficial ownership of 909,090
shares of Common Stock issuable upon exercise of the
Intracoastal Warrant
, and all such shares of Common Stock in the aggregate
represent beneficial ownership of approximately 5.7% of the Common Stock, based on (1) 15,073,455
shares of Common Stock outstanding following the closing of the transactions contemplated by the SPA as reported by the
Issuer, plus (2) 909,090 shares
of Common Stock issuable upon exercise of the Intracoastal Warrant
.

(c) Number of shares
as to which each Reporting Person has:

(1) Sole power to vote or to direct the vote:    0        .

(2) Shared power to vote or to direct the vote:
909,090          
.

(3) Sole power to dispose or to direct the disposition
of        0      .

(4) Shared power to dispose or to direct the disposition
of         909,090          .

 

Item
5. Ownership of Five Percent or Less of a Class

Not applicable.

 

Item
6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

Item
7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

 

Item
8. Identification and Classification of Members of the Group

Not applicable.

 

Item
9. Notice of Dissolution of Group

Not applicable.

 

Item 10. Certification

By signing below I certify
that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection
with a nomination under §240.14a-11.

Page 6 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 7 of 8 – SEC Filing

SIGNATURE

After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: October 11, 2017

/s/ Mitchell P. Kopin
Mitchell P. Kopin
/s/ Daniel B. Asher
Daniel B. Asher
Intracoastal Capital LLC
By: /s/ Mitchell P. Kopin
Mitchell P. Kopin, Manager
Page 7 of 8

Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!

Page 8 of 8 – SEC Filing

Exhibit 1

JOINT FILING AGREEMENT

The undersigned acknowledge
and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent
amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing
additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments,
and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible
for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason
to believe that such information is inaccurate.

Date: October 11, 2017

/s/ Mitchell P. Kopin
Mitchell P. Kopin
/s/ Daniel B. Asher
Daniel B. Asher
Intracoastal Capital LLC
By: /s/ Mitchell P. Kopin
Mitchell P. Kopin, Manager
Page 8 of 8
Follow Aethlon Medical Inc (NASDAQ:AEMD)
Trade (NASDAQ:AEMD) Now!